Atlas Trials

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Clinical trial NCT01220596 · UNKNOWN

Trial details

NCT number
NCT01220596
Sponsor
Hanyang University
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Hepatitis B, Chronic
Start date
2010-06-01
Primary completion
2013-06-01
Enrollment
228

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.